CRISPR/Cpf1-related methods, compositions and components for cancer immunotherapy
- 专利权人:
- Inc.;Editas Medicine
- 发明人:
- Welstead, Gordon Grant,Jayaram, Hariharan,Wang, Tongyao,Zuris, John Anthony,Borges, Christopher
- 申请号：
- AU2017226172
- 公开号：
- AU2017226172A2
- 申请日:
- 2017.03.03
- 申请国别(地区):
- AU
- 年份:
- 2018
- 代理人:
- 摘要：
- CRISPR/Cpf1 -related compositions and methods for treatment of cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Use of NOX inhibitors for the treatment of cancer
- CRISPR-CPF1-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY
- Methods and components of cancer treatment
- COMPOSITIONS FOR THE LIQUIDATION OF TUMORS AND USES THEREOF
- COMPOSITIONS FOR THE TREATMENT OF CANCER USING ANTAGONISTS CONNECTING TO THE PD-1 SIGNAL WAY COMPONENT AND MEK INHIBITORS
